Treatment of hepatitis C with daily induction dose interferon alpha 2b plus ribavirin followed by daily combination therapy in patients who are treatment naive or have previously failed an interferon based therapy.

被引：0
|
作者：
Lawitz, EJ [1 ]
Kadakia, SC [1 ]
Cantu, N [1 ]
Nader, P [1 ]
Cox, J [1 ]
Ganeshappa, KP [1 ]
Reddy, G [1 ]
Nguyen, TT [1 ]
Diamond, K [1 ]
Lindner, M [1 ]
Ostower, V [1 ]
Vemura, R [1 ]
机构：
[1] Brooke Army Med Ctr, San Antonio, TX USA
来源：
GASTROENTEROLOGY | 2000年 / 118卷 / 04期
关键词：
D O I：
10.1016/S0016-5085(00)81746-1
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
6625
引用
收藏
页码：A1462 / A1462
页数：1
相关论文
共 50 条
  • [1] A multi-center trial using daily induction dose interferon alpha 2b plus ribavirin followed by daily interferon alpha 2b+ribavirin in patients with chronic hepatitis C who have previously failed an interferon based therapy.
    Lawitz, EJ
    Kadakia, SC
    Cantu, NS
    Nader, P
    Diamond, K
    Ganeshappa, KP
    Mehta, SN
    Reddy, G
    Nguyen, T
    Lindner, M
    Fixelle, AM
    Goodpasture, H
    HEPATOLOGY, 2000, 32 (04) : 559A - 559A
  • [2] Comparison of daily induction dose interferon alpha 2b plus ribavirin followed by daily combination therapy versus standard combination therapy in treatment naive patients with chronic hepatitis C.
    Lawitz, EJ
    Kadakia, SC
    Cantu, N
    Jeffries, MA
    Schutz, SM
    Matossian, H
    Jolley, JJ
    Sheinbaum, AJ
    Meadows, JG
    GASTROENTEROLOGY, 2000, 118 (04) : A1461 - A1461
  • [3] Alfa interferon 2b and Ribavirin for treatment of patients with chronic hepatitis C who have failed alpha interferon 2b as single therapy.
    Blanchard, D
    Reed, T
    Freeman, S
    Weiner, K
    Bader, T
    HEPATOLOGY, 1998, 28 (04) : 284A - 284A
  • [4] A multi-center trial using daily induction dose interferon alpha 2b plus ribavirin followed by daily interferon alpha 2b+ribavirin in patients with chronic hepatitis C who are treatment naive.
    Lawitz, EJ
    Kadakia, SC
    Cantu, NS
    Nader, P
    Diamond, K
    Ganeshappa, KP
    Cox, J
    Reddy, G
    Nguyen, T
    Lindner, M
    Fixelle, AM
    Goodpasture, H
    HEPATOLOGY, 2000, 32 (04) : 556A - 556A
  • [5] PEG-interferon α-2b plus ribavirin for treatment of patients with chronic hepatitis C who have previously failed to achieve a sustained virologic response following interferon A or interferon α-2b plus ribavirin therapy.
    Sulkowski, M
    Rothstein, KD
    Stein, L
    Godofsky, E
    Shoultz, D
    Hudnall, R
    Huff, M
    Dieterich, D
    HEPATOLOGY, 2001, 34 (04) : 419A - 419A
  • [6] A multi-center randomized trial comparing daily induction dose interferon alpha 2b plus ribavirin followed by daily combination therapy versus standard combination therapy in treatment naive patients with chronic hepatitis C.
    Lawitz, EJ
    Kadakia, SC
    Cantu, NS
    Jeffries, MA
    Schutz, SM
    Sheinbaum, A
    Torivara, N
    Jolley, JJ
    Matossian, H
    Moulis, H
    Glombicki, AP
    Galen, E
    HEPATOLOGY, 2000, 32 (04) : 556A - 556A
  • [7] Preliminary report:: Efficacy of high dose daily induction interferon α-2b plus ribavirin followed by continuing daily interferon α-2b plus ribavirin in the treatment of hepatitis C.
    King, JW
    Favrot, DR
    Markanday, A
    HEPATOLOGY, 1999, 30 (04) : 629A - 629A
  • [8] Combination treatment with interferon alfa-2b and ribavirin for chronic hepatitis C in patients who have failed interferon therapy.
    Birdi, PK
    Wustrack, S
    Rostetter, E
    King, JW
    Balart, LA
    GASTROENTEROLOGY, 2000, 118 (04) : A1426 - A1426
  • [9] Combination therapy with ribavirin plus alpha-interferon is beneficial for the treatment of chronic hepatitis C in patients who have failed treatment with alpha-interferon
    Kwo, PY
    Pound, DC
    Fields, S
    Glowinski, EA
    Born, L
    Chalasani, N
    Chu, W
    Crabb, DW
    Cummings, OW
    Imperiale, T
    Lumeng, L
    McGill, JM
    Ness, R
    Pitozzi, R
    Jones, B
    Pappas, SC
    Rusche, HR
    Maier, J
    Hurwich, D
    O'Dea, P
    Isenberg, M
    Van Dyke, V
    GASTROENTEROLOGY, 1999, 116 (04) : A1235 - A1235
  • [10] Combination therapy with ribavirin plus alpha-interferon is beneficial for the treatment of chronic hepatitis C in patients who have failed treatment with alpha-interferon.
    Kwo, PY
    Pound, DC
    Fields, S
    Glowinski, EA
    Bom, L
    Chalasani, N
    Cho, W
    Crabb, DW
    Cummings, OW
    Imperiale, T
    Lumeng, L
    McGill, JM
    Ness, R
    Pintozzi, R
    Jones, B
    Pappas, SC
    Rusche, HF
    Maier, J
    Hurwich, D
    O'Dea, P
    HEPATOLOGY, 1998, 28 (04) : 376A - 376A
12345